Haemato Statements
HA
Data from Haemato`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Haemato Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
133.64
5.1 %
100
123.39
92.3
10.243
8 %
7.7
—
0
2.047
1.5
4.985
-10.6 %
3.7
5.258
34.5 %
3.9
-1.478
-1.1
0.001
0.0007
3.781
-55.2 %
2.8
1.5
1.1
2.281
-68.9 %
1.7
0.44
5.184
127.17
5.1 %
100
117.68
92.5
9.486
-21.7 %
7.5
—
0
2.128
1.7
5.578
-27.9 %
4.4
3.908
-10.9 %
3.1
4.537
3.6
—
0
8.445
314.2 %
6.6
1.116
0.9
7.33
749.3 %
5.8
1.402
5.228
120.97
-9.4 %
100
108.85
90
12.121
-11.2 %
10
—
0
2.814
2.3
7.734
-20.4 %
6.4
4.387
11.6 %
3.6
-2.348
-1.9
—
0
2.039
144.2 %
1.7
1.176
1
0.863
271.2 %
0.7
0.165
5.23
133.52
-11.9 %
100
119.87
89.8
13.643
-20.2 %
10.2
—
0
3.689
2.8
9.712
-1.5 %
7.3
3.931
-45.6 %
2.9
-3.096
-2.3
—
0
0.835
-90.2 %
0.6
1.339
1
-0.504
-107.2 %
-0.4
-0.101
4.977
151.53
23.7 %
100
134.44
88.7
17.088
96.8 %
11.3
—
0
3.814
2.5
9.858
19 %
6.5
7.23
1722.9 %
4.8
1.292
0.9
—
0
8.522
534.9 %
5.6
1.484
1
7.038
450 %
4.6
1.35
5.213
122.52
—
100
113.84
92.9
8.682
—
7.1
—
0
3.398
2.8
8.286
—
6.8
0.397
—
0.3
-2.356
-1.9
—
0
-1.96
—
-1.6
0.051
0.04
-2.011
—
-1.6
-0.829
2.426